Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)

Anna C. Ferrari, Joshi J. Alumkal, Mark N. Stein, Mary Ellen Taplin, James Babb, Ethan S. Barnett, Alejandro Gomez-Pinillos, Xiaomei Liu, Dirk Moore, Robert DiPaola, Tomasz M. Beer

Research output: Contribution to journalComment/debate

Abstract

In the original version of this article (1), a sentence was missing in the Results section of the Abstract. The error has been corrected in the latest online HTML and PDF versions of the article. The publisher regrets this error.

Original languageEnglish (US)
Number of pages1
JournalClinical Cancer Research
Volume25
Issue number8
DOIs
StatePublished - Apr 15 2019

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)'. Together they form a unique fingerprint.

  • Cite this